Against the backdrop of swirling healthcare industry pressures over the years, from the expansion and growth of diseases and viruses to the budgetary speedbumps of economic planning...
AAM warns that tariffs on Canada, Mexico, and China could exacerbate drug shortages and increase costs for U.S. patients, urging the Administration to avoid imposing tariffs on...
AHA's press release highlights dangers to patient care from tariffs on medical devices and pharmaceuticals. Concerns include disruption in drug supply and impact on essential ...
